EBNA-2 TRANSACTIVATES A LYMPHOID-SPECIFIC ENHANCER IN THE BAMHI C PROMOTER OF EPSTEIN-BARR-VIRUS

被引:143
作者
SUNG, NS
KENNEY, S
GUTSCH, D
PAGANO, JS
机构
[1] UNIV N CAROLINA,DEPT MICROBIOL,CHAPEL HILL,NC 27514
[2] UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514
[3] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27514
关键词
D O I
10.1128/JVI.65.5.2164-2169.1991
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Among the few Epstein-Barr virus (EBV) genes expressed during latency are the Epstein-Barr nuclear antigens (EBNAs), at least one of which contributes to the ability of the virus to transform B lymphocytes. We have analyzed a promoter located in the BamHI-C fragment of EBV which is responsible for the expression of EBNA-1 in some cell lines. Deletion analysis of a 1.4-kb region 5' of the RNA start site has identified a 700-bp fragment that is required for optimal promoter activity in latently infected B lymphocytes, as shown by promoter constructs linked to the chloramphenicol acetyltransferase reporter gene. This fragment is also able to enhance activity, in an orientation-independent manner, of the simian virus 40 early promoter linked to the chloramphenicol acetyltransferase gene. The enhancer element has some constitutive activity in EBV-negative lymphoid cells, which is increased in the presence of the EBNA-2 gene product. Further deletions have shown that the EBNA-2-responsive region requires a 98-bp region that contains a degenerate octamer-binding motif. In epithelial cells there was no enhancer activity regardless of the presence of EBNA-2. These results demonstrate that BamHI-C promoter activity may be dependent not on an enhancer contained in the ori-P, as was previously assumed, but rather on EBNA-2 transactivation of this more proximal enhancer located in the upstream region of the BamHI C promoter itself.
引用
收藏
页码:2164 / 2169
页数:6
相关论文
共 51 条
  • [1] ABBOT SD, 1990, J VIROL, V64, P2156
  • [2] Ausubel F, 1988, CURRENT PROTOCOLS MO
  • [3] OBP100 BINDS REMARKABLY DEGENERATE OCTAMER MOTIFS THROUGH SPECIFIC INTERACTIONS WITH FLANKING SEQUENCES
    BAUMRUKER, T
    STURM, R
    HERR, W
    [J]. GENES & DEVELOPMENT, 1988, 2 (11) : 1400 - 1413
  • [4] EPSTEIN-BARR VIRUS LATENT INFECTION MEMBRANE-PROTEIN INCREASES VIMENTIN EXPRESSION IN HUMAN B-CELL LINES
    BIRKENBACH, M
    LEIBOWITZ, D
    WANG, F
    SAMPLE, J
    KIEFF, E
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (09) : 4079 - 4084
  • [5] A PROMOTER FOR THE HIGHLY SPLICED EBNA FAMILY OF RNAS OF EPSTEIN-BARR-VIRUS
    BODESCOT, M
    PERRICAUDET, M
    FARRELL, PJ
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (11) : 3424 - 3430
  • [6] EPSTEIN-BARR-VIRUS (EBV) INDUCES EXPRESSION OF B-CELL ACTIVATION MARKERS ON INVITRO INFECTION OF EBV-NEGATIVE B-LYMPHOMA CELLS
    CALENDER, A
    BILLAUD, M
    AUBRY, JP
    BANCHEREAU, J
    VUILLAUME, M
    LENOIR, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) : 8060 - 8064
  • [7] EPSTEIN-BARR VIRUS NUCLEAR PROTEIN-2 IS A KEY DETERMINANT OF LYMPHOCYTE-TRANSFORMATION
    COHEN, JI
    WANG, F
    MANNICK, J
    KIEFF, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) : 9558 - 9562
  • [8] EXPRESSION OF THE EPSTEIN-BARR-VIRUS NUCLEAR PROTEIN-2 IN RODENT CELLS
    DAMBAUGH, T
    WANG, F
    HENNESSY, K
    WOODLAND, E
    RICKINSON, A
    KIEFF, E
    [J]. JOURNAL OF VIROLOGY, 1986, 59 (02) : 453 - 462
  • [9] IMMEDIATE-EARLY GENE REGION OF HUMAN CYTOMEGALOVIRUS TRANS-ACTIVATES THE PROMOTER OF HUMAN-IMMUNODEFICIENCY-VIRUS
    DAVIS, MG
    KENNEY, SC
    KAMINE, J
    PAGANO, JS
    HUANG, ES
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) : 8642 - 8646
  • [10] NASOPHARYNGEAL CARCINOMA .10. PRESENCE OF EPSTEIN-BARR GENOMES IN SEPARATED EPITHELIAL-CELLS OF TUMORS IN PATIENTS FROM SINGAPORE, TUNISIA AND KENYA
    DESGRANGES, C
    WOLF, H
    DETHE, G
    SHANMUGARATNAM, K
    CAMMOUN, N
    ELLOUZ, R
    KLEIN, G
    LENNERT, K
    MUNOZ, N
    ZURHAUSEN, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (01) : 7 - 15